ATE437366T1 - Verfahren zur direkten auswahl von antigen- spezifischen t-zellen - Google Patents

Verfahren zur direkten auswahl von antigen- spezifischen t-zellen

Info

Publication number
ATE437366T1
ATE437366T1 AT99924167T AT99924167T ATE437366T1 AT E437366 T1 ATE437366 T1 AT E437366T1 AT 99924167 T AT99924167 T AT 99924167T AT 99924167 T AT99924167 T AT 99924167T AT E437366 T1 ATE437366 T1 AT E437366T1
Authority
AT
Austria
Prior art keywords
cells
antigen
product
labeled
specific
Prior art date
Application number
AT99924167T
Other languages
English (en)
Inventor
Mario Assenmacher
Stefan Miltenyi
Jurgen Schmitz
Original Assignee
Miltenyi Biotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miltenyi Biotec Gmbh filed Critical Miltenyi Biotec Gmbh
Application granted granted Critical
Publication of ATE437366T1 publication Critical patent/ATE437366T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99924167T 1998-05-11 1999-05-10 Verfahren zur direkten auswahl von antigen- spezifischen t-zellen ATE437366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8513698P 1998-05-11 1998-05-11
PCT/US1999/010200 WO1999058977A1 (en) 1998-05-11 1999-05-10 Method of direct selection of antigen-specific t cells

Publications (1)

Publication Number Publication Date
ATE437366T1 true ATE437366T1 (de) 2009-08-15

Family

ID=22189678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924167T ATE437366T1 (de) 1998-05-11 1999-05-10 Verfahren zur direkten auswahl von antigen- spezifischen t-zellen

Country Status (10)

Country Link
US (2) US6576428B1 (de)
EP (1) EP1078263B1 (de)
JP (1) JP4601166B2 (de)
AT (1) ATE437366T1 (de)
AU (1) AU765085B2 (de)
CA (1) CA2330678C (de)
DE (1) DE69941150D1 (de)
DK (1) DK1078263T3 (de)
ES (1) ES2328650T3 (de)
WO (1) WO1999058977A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332884T2 (de) * 1992-10-21 2003-11-20 Stefan Miltenyi Direkte auswahl von zellen durch ein aussheidungsprodukt
US7166423B1 (en) 1992-10-21 2007-01-23 Miltenyi Biotec Gmbh Direct selection of cells by secretion product
CA2341742A1 (en) * 1998-08-24 2000-03-02 Maxim Pharmaceuticals, Inc. Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
US7807377B2 (en) * 1998-10-20 2010-10-05 Salvatore Albani Method of isolating antigen-specific T cells employing artificial antigen presenting cells
US20020044656A1 (en) * 1999-10-13 2002-04-18 Brant L. Candelore Interfacing a conditional access circuit to a digital device using input and output stream switching
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
AU5984701A (en) 2000-05-12 2001-11-20 Univ Oregon Health & Science Method of treating immune pathologies with low dose estrogen
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
JP2002365286A (ja) * 2000-11-13 2002-12-18 Kyogo Ito 細胞性免疫検出法およびその医薬への応用
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
WO2002057423A2 (en) 2001-01-16 2002-07-25 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
GB0118337D0 (en) * 2001-07-27 2001-09-19 Lonza Biologics Plc Method for selecting antibody expressing cells
US20060035291A1 (en) * 2001-09-18 2006-02-16 Kyogo Itoh Method of detecting cellular immunity and application thereof to drugs
US20050084967A1 (en) * 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
AU2003253684A1 (en) * 2002-06-28 2004-01-19 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
DE50207025D1 (de) * 2002-08-23 2006-07-06 Deutsches Rheuma Forschungszen Verfahren zum Nachweis und zur Isolierung von T-Lymphozyten, die ein definiertes Antigen erkennen
WO2004051268A1 (en) 2002-12-03 2004-06-17 Celltech R & D Limited Assay for identifying antibody producing cells
US20040248205A1 (en) * 2003-04-16 2004-12-09 Stern Lawrence J. Major histocompatibility complex (MHC)-peptide arrays
DK1623017T3 (da) * 2003-05-08 2011-01-10 Life Technologies Corp Frembringelse og isolering af antigenspecifikke T-celler
EP1658498A1 (de) * 2003-08-20 2006-05-24 Celltech R & D Limited Verfahren zur gewinnung von antikörpern
WO2005031357A2 (en) * 2003-09-24 2005-04-07 Ucl Biomedica Plc. Cell sample analysis
ATE456048T1 (de) * 2004-05-24 2010-02-15 Baylor Res Inst Verfahren zur beurteilung von immunreaktionen
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
GB0412973D0 (en) * 2004-06-10 2004-07-14 Celltech R&D Ltd Identification of antibody producing cells
WO2006012641A2 (en) 2004-07-30 2006-02-02 Oregon Health And Science University Methods for detecting and treating autoimmune disorders
AU2005302425A1 (en) * 2004-10-29 2006-05-11 Benaroya Research Institute At Virginia Mason Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use
WO2006124356A2 (en) * 2005-05-16 2006-11-23 The Rockefeller University Method for isolating dermal papilla cells and uses thereof
US7867765B2 (en) * 2005-12-28 2011-01-11 The General Hospital Corporation Blood cell sorting methods and systems
EP1878744A1 (de) * 2006-07-13 2008-01-16 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Epitope-Tag für an der Oberfläche exprimierte T-Zell Rezeptor Proteine, deren Anwendung und Verfahren zur Selection von Wirtszellen, die sie exprimieren
WO2008016431A2 (en) * 2006-07-29 2008-02-07 Robert Lamar Bjork Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug
CN101221171B (zh) * 2007-12-11 2011-07-20 广州益善生物技术有限公司 用于骨代谢生化标志物检测的液相芯片及其制备方法
WO2009103753A1 (en) * 2008-02-20 2009-08-27 Ablynx Nv Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods
US20110177592A1 (en) * 2008-07-11 2011-07-21 Faustman Denise L Magnetic apparatus for blood separation
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
GB0823553D0 (en) * 2008-12-24 2009-01-28 Immunosolv Ltd Cell separation technique
US20120045827A1 (en) * 2009-03-09 2012-02-23 Biofactura, Inc. Separation of antigen-specific memory b cells with a conjugated biopolymer surface
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
CN102033129A (zh) * 2009-09-29 2011-04-27 上海英伯肯医学生物技术有限公司 用抗原刺激的细胞免疫反应来检测病原微生物的方法及测试笔
EP2390661B1 (de) * 2010-05-02 2015-06-24 Miltenyi Biotec GmbH Verankerungs-/Erfassungsmittel zum Auswählen oder Analysieren einer CHO-Zelle entsprechend einem Produkt, das von der CHO-Zelle sezerniert wird
EP2625264B1 (de) 2010-10-08 2022-12-07 Terumo BCT, Inc. Verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem mit steuerungsbedingungen
EP2518504A1 (de) * 2011-04-29 2012-10-31 Miltenyi Biotec GmbH Verfahren zur quantitativen und qualitativen Charakterisierung von antigenspezifischen T-Zellen, die ein spezifischen Antigen erkennen
AU2012258603A1 (en) 2011-05-26 2014-01-16 Geneius Biotechnology, Inc. Modulated immunodominance therapy
ES2864323T3 (es) * 2011-12-22 2021-10-13 Yeda Res & Dev Una terapia de combinación para un injerto estable y a largo plazo
JP2015528293A (ja) 2012-08-29 2015-09-28 イングラン， エルエルシー 損傷または欠陥のある細胞または細胞組織の磁気的除去または識別
US10379026B2 (en) 2012-08-29 2019-08-13 Inguran, Llc Cell processing using magnetic particles
TWI745610B (zh) 2012-11-14 2021-11-11 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
EP3068866B1 (de) 2013-11-16 2018-04-25 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
CN103901188B (zh) * 2014-04-11 2016-08-24 苏州浩欧博生物医药有限公司 一种吸入过敏原的化学发光定量检测试剂盒及其制备方法和检测方法
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3397755B1 (de) * 2015-12-28 2024-11-06 Novartis AG Verfahren zur herstellung von chimeren antigen rezeptor exprimierenden zellen
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7034955B2 (ja) * 2016-06-28 2022-03-14 ジーニアス・バイオテクノロジー・インコーポレイテッド 免疫療法向けのｔ細胞組成物
US11702634B2 (en) 2017-03-31 2023-07-18 Terumo Bct, Inc. Expanding cells in a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US20200371087A1 (en) * 2017-08-01 2020-11-26 Benaroya Research Institute At Virginia Mason Methods for identifying and separating pro-allergic specific t cells
CN110857948B (zh) * 2018-08-24 2025-01-21 武汉纳达康生物科技有限公司 H7禽流感病毒抗体磁免疫化学发光检测试剂盒及其应用
MX2021004355A (es) * 2018-10-19 2021-05-31 Eth Zuerich Moleculas quimericas.
US20220282240A1 (en) * 2019-08-14 2022-09-08 Sanford Burnham Prebys Medical Discovery Institute Methods and devices for rare cell capture
JP2022093945A (ja) * 2020-12-14 2022-06-24 株式会社山田養蜂場本社 Ｂ細胞数増加剤
US12043823B2 (en) 2021-03-23 2024-07-23 Terumo Bct, Inc. Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN117433867A (zh) * 2023-10-24 2024-01-23 深圳联合医学科技有限公司 阴道微生物的荧光染色液及检测阴道微生物的方法
WO2025151270A2 (en) * 2024-01-08 2025-07-17 Board Of Regents, The University Of Texas System Microfluidic device for rapid enrichment of anti-tumor t-cells and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4452773A (en) 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
GB8408127D0 (en) 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
IL91414A0 (en) 1988-08-31 1990-04-29 Zynaxis Technologies Inc Reagents and methods for the determination of analytes
US5385707A (en) 1988-12-28 1995-01-31 Stefan Miltenyi Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same
WO1990007380A2 (en) 1988-12-28 1990-07-12 Stefan Miltenyi Methods and materials for high gradient magnetic separation of biological materials
DE69332884T2 (de) * 1992-10-21 2003-11-20 Stefan Miltenyi Direkte auswahl von zellen durch ein aussheidungsprodukt
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
US6143292A (en) 1995-05-25 2000-11-07 Baxter International Inc. Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
CA2227327A1 (en) 1995-07-25 1997-02-13 Celltherapy, Inc. Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
AU740222C (en) 1996-03-20 2002-10-10 Genzyme Corporation A method for identifying cytotoxic T-cell epitopes
DE69737070T2 (de) 1996-05-23 2007-06-21 The Scripps Research Institute, La Jolla Systeme zur präsentation von mhc-antigenen der klasse ii und verfahren zur aktivierung von cd4?+-t-lymphozyten
US5750356A (en) 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity

Also Published As

Publication number Publication date
AU4073699A (en) 1999-11-29
JP2002514765A (ja) 2002-05-21
WO1999058977A1 (en) 1999-11-18
US6576428B1 (en) 2003-06-10
EP1078263B1 (de) 2009-07-22
CA2330678C (en) 2009-04-07
CA2330678A1 (en) 1999-11-18
JP4601166B2 (ja) 2010-12-22
US20040023377A1 (en) 2004-02-05
EP1078263A1 (de) 2001-02-28
AU765085B2 (en) 2003-09-11
DE69941150D1 (de) 2009-09-03
ES2328650T3 (es) 2009-11-16
DK1078263T3 (da) 2009-11-02

Similar Documents

Publication Publication Date Title
ATE437366T1 (de) Verfahren zur direkten auswahl von antigen- spezifischen t-zellen
KR950704475A (ko) 분비 생성물에 의한 직접적인 세포 선별(direct selection of cells by se-cretion product)
PL316209A1 (en) Method of and apparatus for detecting specific target cells in specialised or mixed cell populations and solutions containing moxed populations of cells
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE97500T1 (de) Verfahren zur unterscheidung zwischen intakten und beschaedigten zellen in einer probe.
PL328272A1 (en) Methods of and compositions for detecting ligand pair bonds using non-fluoroscent labelling
EP0850417A4 (de) Effiziente anreicherung und detektion von ausgesäten tumorzellen
DE69626418D1 (de) Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation
DE69721258T2 (de) Markierung und auswahl von molekülen
Laghmouchi et al. Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells
WO2002087792A8 (en) Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles
Peters et al. A leucine-rich repeat variant with a novel repetitive protein structural motif
DE60314898D1 (de) Zusammensetzungen und verfahren zur trennung von zellen
ATE320314T1 (de) Verfahren zur modifikation von ausgewählten zellen in einer magnetischen zelltrennungsäule
DE69633740D1 (de) Verfahren zur auswahl einer population oder subpopulation einer probe unter verwendung von partikel-und schwerkraft -sedimentation
ATE120796T1 (de) Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.
TW215898B (de)
WO1993020103A3 (en) Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification
SE8603312D0 (sv) Sett att overvaka fermentering

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties